Log in to save to my catalogue

Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphom...

Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphom...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2333611416

Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma—a long-term follow-up single center experience

About this item

Full title

Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma—a long-term follow-up single center experience

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Annals of hematology, 2020-02, Vol.99 (2), p.265-276

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Autologous stem cell transplantation (autoSCT) can achieve long-term remission in primary refractory or relapsed Hodgkin lymphoma (r/r HL); however, still up to 50% of patients relapse after autoSCT. In this retrospective analysis, we investigated the impact of autologous stem cell transplantation in a consecutive, unselected cohort of primary refr...

Alternative Titles

Full title

Outcome after autologous stem cell transplantation in primary refractory or relapsed Hodgkin lymphoma—a long-term follow-up single center experience

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2333611416

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2333611416

Other Identifiers

ISSN

0939-5555

E-ISSN

1432-0584

DOI

10.1007/s00277-019-03900-x

How to access this item